Publications

Journal Article
Review
Ppublish 29 citations
Electronic publication date
November 4, 1997

View on Pubmed.gov 9323715 | View on doi.org 10.1159/0002680...

Ocular gene therapy: experimental studies and clinical possibilities.

Search for publications in this journal Ophthalmic Res - 29(5):242-51

Abstract

The Human Genome Project will identify, map and sequence all 50,000-100,000 human genes and will provide the tools to determine the genetic basis of both common and rare diseases. Understanding the genetic basis of human disease will allow for the development of highly specific drugs and for replacement of the altered gene through gene therapy. Gene therapy may also be used to introduce a new function into cells with resulting therapeutic benefit. Genes may be delivered into cells in vitro or in vivo utilizing viral or nonviral vectors. Viral vectors which have been used include retroviruses, adenoviruses, adeno-associated viruses and herpes viruses. Ocular disorders with the greatest potential for benefit of gene therapy at the current time include hereditary ocular diseases, including retinitis pigmentosa, tumors such as retinoblastoma or melanoma, and acquired proliferative and neovascular retinal disorders. We have demonstrated the feasibility of ocular gene therapy in a rabbit model of proliferative vitreoretinopathy, using retroviral vectors containing the herpes simplex virus thymidine kinase 'suicide' gene. Although in vivo transduction efficiency is low, the strong bystander effect results in prominent killing of proliferating cells in this model leading to inhibition of disease. In the future, gene therapy has the potential for the replacement of defective gene products or introduction of new gene products into ocular cells. The selection of appropriate target genes and cells will be critical, as will the development of a methodology for safe, targeted gene transfer.

References

No references provided.

Cited by 29 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity.

Electronic publication date September 8, 2001

Search for publications in this journal Br J Ophthalmol

I Chowers [...] A Panet et al.

AIMS

To test the feasibility of gene transfer into hyaloid blood vessels and into preretinal neovascularisation in a rat model of...

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy.

Electronic publication date December 14, 2010

Search for publications in this journal Am J Pathol

Hetian Lei [...] Andrius Kazlauskas et al.

Proliferative vitreoretinopathy (PVR) is a complication that develops in 5% to 10% of patients who undergo surgery to correct a...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances